For the quarter ending 2025-12-31, NNVC has $12,267,640 in assets. $5,150,580 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 5,150,580 | 1,125,711 | 1,558,564 | |
| Prepaid expenses | 145,985 | 126,855 | 112,146 | |
| Total current assets | 5,296,565 | 1,252,566 | 1,670,710 | |
| Property and equipment, net | 6,656,439 | 6,787,456 | 6,833,891 | |
| Intangible assets, total | 458,954 | 458,954 | 458,954 | |
| Less accumulated amortization | 146,050 | 143,983 | 141,915 | |
| Intangible assets, net | 312,904 | 314,971 | 317,039 | |
| Service agreements | 1,732 | 2,087 | 2,445 | |
| Total assets | 12,267,640 | 8,357,080 | 8,824,085 | |
| Accounts payable-Nonrelated Party | 218,313 | 254,943 | 459,094 | |
| Accounts payable-Related Party | 929,232 | 901,143 | 821,456 | |
| Accrued expenses | 48,380 | 26,300 | 25,969 | |
| Total current liabilities | 1,195,925 | 1,182,386 | 1,306,519 | |
| Series a convertible preferred stock, 0.00001 par value, 10,000,000 shares designated, 916,695 and 905,717 shares issued and outstanding, at december 31, 2025 and june 30, 2025, respectively-Series AConvertible Preferred Stock | 9 | 9 | 9 | |
| Common stock, 0.00001 par value 150,000,000 shares authorized, 21,595,187 and 16,606,832 shares issued and outstanding, at december 31, 2025 and june 30, 2025, respectively | 216 | 176 | 166 | |
| Additional paid-in capital | 163,919,128 | 157,801,428 | 156,359,252 | |
| Accumulated deficit | -152,847,638 | -150,626,919 | -148,841,861 | |
| Total stockholders' equity | 11,071,715 | 7,174,694 | 7,517,566 | |
| Total liabilities and stockholders' equity | 12,267,640 | 8,357,080 | 8,824,085 | |
NANOVIRICIDES, INC. (NNVC)
NANOVIRICIDES, INC. (NNVC)